Vision Net, a leading provider of network and technology solutions for carriers, enterprise businesses, healthcare organizations, and educational institutions, announced a series of significant ...
Suven Life Sciences surged 9.51% to Rs 138.70 after the firm dosed first subjects in a Phase-1 clinical trial of SUVN-I6107 being conducted in USA under FDA acceptance of investigational new drug (IND ...
Shares of Vir Biotechnology (CIR) climbed ~42% in the premarket on Wednesday after the company posted initial Phase 1 data ...
The first MAPS 4 bus stop improvements are complete and open for service in northeast Oklahoma City.According to the City of Oklahoma City, the project will imp ...
The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small ...
With an aggregate of $11 million raised in an initial Series A funding round, Doron Therapeutics is advancing its lead ...
CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...
Results support advancing LB-102 to Phase 3 clinical development in schizophrenia . NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) ...
New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...
Ellen Green, a postgraduate researcher with the University of Reading, analyzed “Quarry 1” from the Nescot site and found “it ...
Viking Therapeutics (VKTX) announced the initiation of a Phase 2 clinical trial of the oral tablet formulation of VK2735, the company’s dual ...
The city of Chico announced that it has been awarded a $12,746,798 grant to fund an innovative fiber utility project aimed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback